Quality Analysis of Raw and Processed Schisandra Chinensis Fructus by Simultaneous Determination of Eleven Bioactive Lignans Using RP-HPLC Method

A reversed-phase high-performance liquid chromatography (RP-HPLC) method was developed for the simultaneous determination of eleven bioactive lignans, namely schisandrin, gomisin J, schisandrol B, angeloylgomisin H, gomisin G, schisantherin A, schisantherin B, deoxyschisandrin, γ-schisandrin, schisandrin B and schisandrin C in Schisandra chinensis with UV detection. An Elite ODS C18 column (250 mm × 4.6 mm, 5 μm) was used for chromatographic separation. The mobile phase consisted of acetonitrile and water under gradient elution. All the calibration curves of the eleven bioactive lignans showed excellent linearity (r ≥ 0.9995) within the ranges of 25.02-150.1 μg/mL for schisandrin, 5.20-31.20 μg/mL for gomisin J, 10.99-65.94 μg/mL for schisandrol B, 14.10-84.60 μg/mL for angeloylgomisin H, 2.55-15.30 μg/mL for gomisin G, 3.79-22.74 μg/mL for schisantherin A, 8.32-49.92 μg/mL for schisantherin B, 5.16-30.96 μg/mL for deoxyschisandrin, 9.10-54.60 μg/mL for γ-schisandrin, 20.70-124.2 μg/mL for schisandrin B and 4.56-27.36 μg/mL for schisandrin C. The average recoveries ranged from 97.74 to 102.71%. This analytical method was also validated with respect to precision, repeatability and accuracy; and it was proven to be sensitive and accurate to simultaneously determine the eleven lignans in S. chinensis. The developed method was further applied to quantify the contents of the eleven lignans in raw and processed S. chinensis. The results revealed that the contents of the eleven lignans increased after processing with vinegar and wine. The lignans profiles obtained by this newly established method provided valuable information for the differentiation of crude and processed S. chinensis and the different effects. These content ratio differences could provide a scientific basis for the selection of origins and clinical usage.

[1]  C. Che,et al.  Inhibitory effect of schisandrin on spontaneous contraction of isolated rat colon. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[2]  Tan Jun Determination of schisandrin,schisandrol B and deoxyschizandrin in Fufang Yiganling Pian by HPLC , 2011 .

[3]  Z. Tao Content Determination of Schizandrin in Shengmai Injection by RP-HPLC , 2010 .

[4]  A. Panossian,et al.  Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. , 2008, Journal of ethnopharmacology.

[5]  Jing Jin,et al.  Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae , 2008, Cancer Chemotherapy and Pharmacology.

[6]  Qu Haibin Simultaneous Determination of Five Lignan Compounds in Tangke Capsules by HPLC , 2008 .

[7]  Shiping Ma,et al.  Sedative and hypnotic activities of the ethanol fraction from Fructus Schisandrae in mice and rats. , 2007, Journal of ethnopharmacology.

[8]  B. Holmbom,et al.  Chromatographic analysis of lignans. , 2006, Journal of chromatography. A.

[9]  Wang Li-wei,et al.  Chemical constituents from the fruit of Schisandra Chinensis , 2006 .

[10]  Chen Xingguo,et al.  Separation and determination of active components in Schisandra chinensis Baill. and its medicinal preparations by non-aqueous capillary electrophoresis. , 2005, Biomedical chromatography : BMC.

[11]  I. Khan,et al.  Quantitative Determination of Lignan Constituents from Schisandra chinensis by Liquid Chromatography , 2005 .

[12]  Zhang Yun-yi Effects of Heteroclitin D,Schisanhenol and (+)-Anwulignan on Platelet Aggregation , 2005 .

[13]  S. Kim,et al.  Dibenzocyclooctadiene lignans from Schisandra chinensis protect primary cultures of rat cortical cells from glutamate‐induced toxicity , 2004, Journal of neuroscience research.

[14]  T. Adachi,et al.  Use of synthetic adsorbents in preparative normal-phase liquid chromatography. , 2003, Journal of chromatography. A.

[15]  J. Hancke,et al.  Schisandra chinensis (Turcz.) Baill , 1999 .

[16]  A. Tanaka,et al.  Anti-human immunodeficiency virus (HIV) activities of halogenated gomisin J derivatives, new nonnucleoside inhibitors of HIV type 1 reverse transcriptase , 1995, Antimicrobial agents and chemotherapy.